- This event has passed.
Alliance Discussion with David Ridley, Duke University’s Fuqua School of Business
October 3 @ 11:00 am - 11:45 am
Incentivizing Hard-won Solutions
David Ridley joined us to discuss Priority Review Vouchers (PRV)s.The PRV is an R&D investment incentive designed to spur development in areas of unmet medical need. The first PRV program, focused on the development of drugs for neglected tropical diseases (NTDs), was signed into law in 2007, and subsequent legislation expanded the availability of this incentive to include drugs for rare pediatric diseases and medical countermeasures.
Dr. Ridley walked us through a quick “PRV 101” and shared his thoughts on the future of these and other incentives aimed at addressing critical gaps in R&D investment.